Valsartan Tablet, Film Coated
Product Images NDC 51655-456

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 51655-456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 456 52)

NDC 51655-456-52 is a prescription drug labeled as Valsartan tablets USP with a strength of 160mg. The package contains 30 tablets and should be stored at 25°C with excursions permitted between 15-30°C. This drug should be kept out of reach of children and repackaged by Northwind Pharmaceuticals from Macieods Pharma USA. The drug is intended for use under prescription only.*

FDA Label Image

111 (Valsartan Figure1)

This table shows subgroups of patients in a study comparing the medications Valsartan and Captopril. The subgroups are divided by age, gender, race, location, and beta-blocker use. The numbers in each subgroup indicate the number of patients in that category who were included in the study. The bottom row shows the number of patients favoring Valsartan or Captopril at different time points.*

FDA Label Image

Valsartan (Valsartan Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.